SEC Form 4 · accession 0001193125-26-393422
TENET HEALTHCARE CORP · THC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
J Robert Kerrey
Director
Period of report
Sep 14, 2026
Accepted (ET)
Sep 16, 2026 · 8:00 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000070318
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 14, 2026 | S | 5,483 | $263.04 | D | 11,321 | D | |
| Common StockF2 | Sep 14, 2026 | S | 4,025 | $264.10 | D | 7,296 | D | |
| Common StockF3 | Sep 14, 2026 | S | 2,502 | $264.62 | D | 4,794 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $262.43 to $263.37.
- F2The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $263.45 to $264.44.
- F3The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $264.45 to $265.02.